114 related articles for article (PubMed ID: 17396230)
1. The thrombolytic effect of aspirin in animal model.
Karmohapatra SK; Kahn NN; Sinha AK
J Thromb Thrombolysis; 2007 Oct; 24(2):123-9. PubMed ID: 17396230
[TBL] [Abstract][Full Text] [Related]
2. The role of nitric oxide in aspirin induced thrombolysis in vitro and the purification of aspirin activated nitric oxide synthase from human blood platelets.
Karmohapatra SK; Chakraborty K; Kahn NN; Sinha AK
Am J Hematol; 2007 Nov; 82(11):986-95. PubMed ID: 17636472
[TBL] [Abstract][Full Text] [Related]
3. The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-alpha, a potent inhibitor of platelet aggregation and a thrombolytic agent.
Bhattacharyya M; Karmohapatra SK; Bhattacharya G; Bhattacharya R; Sinha AK
J Thromb Thrombolysis; 2009 Aug; 28(2):173-84. PubMed ID: 18846318
[TBL] [Abstract][Full Text] [Related]
4. Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Evidence for a possible role of inhibiting platelet activity in thrombolysis.
Terres W; Beythien C; Kupper W; Bleifeld W
Circulation; 1989 Jun; 79(6):1309-14. PubMed ID: 2720929
[TBL] [Abstract][Full Text] [Related]
5. Estriol-induced fibrinolysis due to the activation of plasminogen to plasmin by nitric oxide synthesis in platelets.
Jana P; Maiti S; Kahn NN; Sinha AK
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):316-23. PubMed ID: 24695088
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
[TBL] [Abstract][Full Text] [Related]
7. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of thrombogenesis during pharmacological thrombolysis.
Korbut R; Gryglewski RJ
Pol J Pharmacol; 1996; 48(1):85-8. PubMed ID: 9112633
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
11. Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease.
Hallén J; Atar D; Serebruany V
Am J Ther; 2014; 21(2):91-8. PubMed ID: 19770797
[TBL] [Abstract][Full Text] [Related]
12. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
Kobzar G; Mardla V; Samel N
Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of recombinant staphylokinase and streptokinase on platelet aggregation.
Abdelouahed M; Hatmi M; Helft G; Emadi S; Elalamy I; Samama MM
Thromb Haemost; 1997 May; 77(5):815-7. PubMed ID: 9184383
[TBL] [Abstract][Full Text] [Related]
14. Thrombus resistance to lysis and reocclusion after thrombolysis: the role of platelets.
Parise P; Agnelli G
Blood Coagul Fibrinolysis; 1991 Dec; 2(6):749-58. PubMed ID: 1799662
[TBL] [Abstract][Full Text] [Related]
15. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
[TBL] [Abstract][Full Text] [Related]
16. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
[TBL] [Abstract][Full Text] [Related]
17. P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.
Dong N; Da Cunha V; Citkowicz A; Wu F; Vincelette J; Larsen B; Wang YX; Ruan C; Dole WP; Morser J; Wu Q; Pan J
Thromb Haemost; 2004 Nov; 92(5):956-65. PubMed ID: 15543321
[TBL] [Abstract][Full Text] [Related]
18. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
19. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
Basista M; Grodzińska L; Swies J
Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480
[TBL] [Abstract][Full Text] [Related]
20. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
